Imagio OA/US for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Breast CancerImagio OA/US - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a new breast cancer imaging system can detect complete breast cancer pathologic responses to neoadjuvant therapy.

Eligible Conditions
  • Breast Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Berzosertib
1
Optional biopsy
1
LS301

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Baseline to Post Surgical Assessment at 6 months

Month 6
Number of masses that correlate with chemotherapy response/no response as assessed by Functional Feature Score Scale at all study timepoints to predict optimal timing for Imagio imaging
Number of metastatic lymph nodes scored using a Lymph Node Scoring Scale that may correlate with chemotherapy response
The number of masses that may exhibit qualitative changes in accordance with Functional Feature Scale as assessed by Imagio OA/US over the course of baseline though follow-up timepoints

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Berzosertib
1
Optional biopsy
1
LS301

Trial Design

1 Treatment Group

Imagio OA/US
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Imagio OA/US · No Placebo Group · N/A

Imagio OA/US
Device
Experimental Group · 1 Intervention: Imagio OA/US · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Imagio OA/US
2015
N/A
~220

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to post surgical assessment at 6 months

Who is running the clinical trial?

Seno Medical Instruments Inc.Lead Sponsor
8 Previous Clinical Trials
3,636 Total Patients Enrolled
5 Trials studying Breast Cancer
2,961 Patients Enrolled for Breast Cancer
American College of RadiologyOTHER
13 Previous Clinical Trials
8,031,229 Total Patients Enrolled
2 Trials studying Breast Cancer
2,187 Patients Enrolled for Breast Cancer
Basak Dogan, MDPrincipal InvestigatorUT Southwestern
2 Previous Clinical Trials
121 Total Patients Enrolled
2 Trials studying Breast Cancer
121 Patients Enrolled for Breast Cancer

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are male or female.\n
You have invasive breast cancer, including primary or recurrent disease.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top